Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/29/2003CN1451377A Elemene injection, and preparing method and use thereof
10/29/2003CN1451376A Curcuma aromatica extract injection, and preparing method and use thereof
10/29/2003CN1451374A Double-layer slow release ibuprofen and pseudoephedrine hydrochloride tablet
10/29/2003CN1451315A Alpha wave emitting enhancing agent, agent capable of leading relaxation state and diet contg. above-mentioned agents
10/29/2003CN1125824C Antiparasitic marcfortines
10/29/2003CN1125823C Ganciclovir sodium hydrate and its preparing process and application
10/29/2003CN1125821C Compounds derived from thophene and benzothiophene, and related utilisation and compsn.
10/29/2003CN1125819C Triazole alcohol antifungal compound and its preparation method
10/29/2003CN1125818C Amino acid derivatives of substituted quinexaline 2,3-dione derivatives as glutamate receptor antagonists
10/29/2003CN1125815C Method for synthesis of quinoline derivatives
10/29/2003CN1125812C Novel modifications to 2-amino-4 (4-fluorobenzylamino)-1-ethoxy. carbonyl-aminobenzene and processes for preparing said compound
10/29/2003CN1125807C Excitatory amino acid receptor modulators
10/29/2003CN1125653C Pharmaceutical formulations containing voriconazole
10/29/2003CN1125651C Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/29/2003CN1125650C Human immunization strengthening medicine
10/29/2003CN1125645C Ointment for treating psoriasis
10/29/2003CN1125644C Ointment for treating acne
10/29/2003CN1125641C Hongkong foot treating ointment
10/29/2003CN1125640C Prophylactic and therapeutic agent for inflammatory intestinal diseases
10/29/2003CN1125639C Paroxetine Compsns
10/29/2003CN1125638C Stable slow release vitamin C preparation and its production process
10/29/2003CN1125637C Application of 5,3',5'-trihydroxy-7-methoxyl dihydroflavone in preparing medicine
10/29/2003CN1125636C Process for preparing particles containing oral 'beta' lactam activity
10/29/2003CN1125635C Enrofloxacine injection or infusion solutions
10/29/2003CN1125601C Powdered prolycopene preparation, mfg. method thereof and use of same
10/29/2003CA2445913A1 Method of treatment
10/28/2003US6639113 Dispersing in an aqueous protecting colloids comprising at least one partially hydrolyzed soybean protein, drying by dehydration and desolventizing; use as additive to foods, pharmaceuticals and/or animal feeds
10/28/2003US6639111 Bind on EP4 subtype receptor selectively and binds on the other subtype receptors weakly; side-effect reduction; autoimmune diseases; asthma; bone disorders; degenerative nerve diseases; sleeping disorders; anticoagulants
10/28/2003US6639105 For inhibiting tumor cell growth
10/28/2003US6639089 Anticancer agents, perfumes or foods and drinks
10/28/2003US6639078 Assays for ligands for nuclear receptors
10/28/2003US6639074 Reacting an alpha -substituted ketone with a cyclic alkylenetetramine in solvent(s) to form a quaternary ammonium salt; reacting with acid in solvent(s) form an alpha -amino ketone; reacting with acyl derivative; dehydrating
10/28/2003US6639051 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/28/2003US6638981 Topical compositions and methods for treating pain
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638978 Glycerol monoester of lauric acid, mixture of capric and caprylic acids, carrier which optionally contains chelating agent
10/28/2003US6638976 3-benzoylphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders
10/28/2003US6638974 Ascorbyl esters for the treatment of cancer
10/28/2003US6638973 Taxane formulations
10/28/2003US6638971 Cocoa extract compounds and methods for making and using the same
10/28/2003US6638969 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
10/28/2003US6638968 Use of prodigiosin for treating diabetes mellitus
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638966 Use of melatonin analogues for induction of general anesthesia
10/28/2003US6638964 Sulfonamide-containing indole compounds
10/28/2003US6638963 Administering melatonin, a melatonin agonist or compound that increases melatonin production
10/28/2003US6638962 Cycloheptene compounds
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638955 Antibiotic oxazolidinone derivatives
10/28/2003US6638954 Δ2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke
10/28/2003US6638953 Indole derivatives as 5-HT receptor antagonist
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638949 Angiogenesis inhibitor is selective, such as a fumagillol derivative like 0-chloroacetylcarbamoyl-Fumagillol, thalidomide, or a selective drug having more than one activity, such as minocycline or penicilliamine which also
10/28/2003US6638948 A free-flowing, amorphous paroxetine hydrochloride composition suitable as a therapeutic agent for premature ejaculation can be prepared by dissolving paroxetine free base in a hydrochloric acid-ethanol solution followed by
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638946 Substituted pyridine or piperidine compounds
10/28/2003US6638945 Quinoline derivatives as inhibitors of MEK enzymes
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638939 6,7-dimethoxyquinazolines and therapeutic use thereof
10/28/2003US6638938 Method for preventing tissue injury from hypoxia
10/28/2003US6638936 Treatment of obesity in mammals, comprising administering to mammal in need of such treatment, treatment of obsessive compulsive disorder in mammals, comprising administering to a mammal treatment of depression in mammals
10/28/2003US6638935 Heteroary1 derivatives and their use as medicaments
10/28/2003US6638934 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist
10/28/2003US6638933 Bicyclic imidazo-3-yl-amine derivatives
10/28/2003US6638932 Derivatives having HIV replication inhibiting properties. The present compounds differ from the known 1,3,5-triazines by structure and by their improved HIV replication inhibiting properties.
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638930 Morpholine and thiomorpholine tachykinin receptor antagonists
10/28/2003US6638928 Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638923 Estra-1,3,5(10),16-tetraene derivatives
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638920 Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
10/28/2003US6638919 Antiviral purine derivatives
10/28/2003US6638918 Chitosan compositions
10/28/2003US6638916 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
10/28/2003US6638915 Anti-viral composition
10/28/2003US6638914 Pharmaceutical administration of adenosine agonists
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638906 Amphiphilic polymers and polypeptide conjugates comprising same
10/28/2003US6638771 Uses an immune reaction to detect soluble liver antigen ("SLA") auto-antibodies
10/28/2003US6638762 Tissue-vectors specific replication and gene expression
10/28/2003US6638727 Intraductally administering an estrogen activity modulator
10/28/2003US6638546 Muscarine antagonist; extracting, fractionating and purifying bioactive molecules from an associated mangrove plant
10/28/2003US6638545 To treat cellulose; oral administration of trans-resveratrol lipase inhibitor; dietetics
10/28/2003US6638543 Comprising an admixture of a natural inhibitor of epidermal growth factor receptor (EGFR) activation or a derivative or analog and a dermatological carrier; antipeeling agents; genistein and other isoflavones and other plant extracts
10/28/2003US6638540 Plant extracts for the treatment of increased bone resorption
10/28/2003US6638539 Trace elements
10/28/2003US6638536 Storage stable allotropic organic compounds; sustained release, bioavailability, solid state crystallized
10/28/2003US6638535 Modified release formulations containing a hypnotic agent
10/28/2003US6638533 Pulse dosage formulations of methylphenidate and method to prepare same
10/28/2003US6638532 Tetracycline—doxycycline antibiotic composition
10/28/2003US6638530 N-(2-anilino)- and pyridino- substituents; mixed with polyoxyethylene glycol and surfactant, mineral acid salt of amino acid or propylene carbonate; absorbability; anticarcinogenic agents, immunosuppressants
10/28/2003US6638525 Pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
10/28/2003US6638524 Cosmetics, foods and beverages supplemented with purified strictinin
10/28/2003US6638523 Administering carnosic acid and/or carnosol
10/28/2003US6638522 Carrier comprising solubilizing amount of propylene glycol monoester of C6-C18 fatty acid and nonionic surfactant
10/28/2003US6638521 Oral liquid mucoadhesive compositions
10/28/2003US6638516 Strain selection of pneumococcal surface proteins
1 ... 5296 5297 5298 5299 5300 5301 5302 5303 5304 5305 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 ... 7860